Medtronic Medical Surgical — Depreciation increased by 17.0% to $62.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.6%, from $51.00M to $62.00M. Over 2 years (FY 2022 to FY 2025), Medical Surgical — Depreciation shows an upward trend with a 7.3% CAGR.
Increasing depreciation may signal recent capital investment in manufacturing capacity, while stable levels indicate consistent asset utilization.
The systematic allocation of the cost of tangible assets used within the Medical Surgical segment over their useful live...
Standard depreciation expense reported by manufacturing-heavy medical device segments.
mdt_segment_medical_surgical_depreciation| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $46.50M | $46.50M | $46.50M | $46.50M | $50.75M | $50.75M | $50.75M | $50.75M | $49.00M | $51.00M | $51.00M | $56.00M | $54.00M | $53.00M | $62.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +9.1% | +0.0% | +0.0% | +0.0% | -3.4% | +4.1% | +0.0% | +9.8% | -3.6% | -1.9% | +17.0% |
| YoY Change | — | — | — | — | +9.1% | +9.1% | +9.1% | +9.1% | -3.4% | +0.5% | — | — | +10.2% | +3.9% | +21.6% |